Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (1): 11-15.DOI: 10.3969/j.issn.1673-8640.2022.01.002
Previous Articles Next Articles
LI Xiaoqian, WANG Zhihui, CHI Yuepeng, WANG Yuhong, XIE Lanpin, LIANG Yachong(
)
Received:2020-12-14
Revised:2021-04-08
Online:2022-01-30
Published:2022-03-07
Contact:
LIANG Yachong
CLC Number:
LI Xiaoqian, WANG Zhihui, CHI Yuepeng, WANG Yuhong, XIE Lanpin, LIANG Yachong. Analysis of diagnostic efficacy of serum MMP-9 with or without Xpert MTB/RIF assay in alveolar lavage fluid and INF-γ release test for pulmonary tuberculosis[J]. Laboratory Medicine, 2022, 37(1): 11-15.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.01.002
| 组别 | 例数 | CRP/(mg/L) | ESR/(mm/h) | IL-15/(ng/L) | IL-8/(ng/L) | TNF-α/(ng/L) |
|---|---|---|---|---|---|---|
| 菌阳肺结核组 | 62 | 33.57±6.35 | 29.68±6.14 | 19.03±4.28 | 139.46±15.37 | 161.53±20.51 |
| 菌阴肺结核组 | 88 | 32.72±5.21 | 28.94±5.67 | 18.45±3.72 | 136.78±16.84 | 158.70±18.89 |
| 非肺结核组 | 50 | 33.51±6.15 | 28.95±6.06 | 18.69±4.18 | 138.36±14.73 | 160.68±18.47 |
| F值 | 1.241 | 0.731 | 1.267 | 1.926 | 1.056 | |
| P值 | 0.241 | 0.616 | 0.183 | 0.241 | 0.152 |
| 组别 | 例数 | CRP/(mg/L) | ESR/(mm/h) | IL-15/(ng/L) | IL-8/(ng/L) | TNF-α/(ng/L) |
|---|---|---|---|---|---|---|
| 菌阳肺结核组 | 62 | 33.57±6.35 | 29.68±6.14 | 19.03±4.28 | 139.46±15.37 | 161.53±20.51 |
| 菌阴肺结核组 | 88 | 32.72±5.21 | 28.94±5.67 | 18.45±3.72 | 136.78±16.84 | 158.70±18.89 |
| 非肺结核组 | 50 | 33.51±6.15 | 28.95±6.06 | 18.69±4.18 | 138.36±14.73 | 160.68±18.47 |
| F值 | 1.241 | 0.731 | 1.267 | 1.926 | 1.056 | |
| P值 | 0.241 | 0.616 | 0.183 | 0.241 | 0.152 |
| 组别 | 例数 | MMP-9/ (ng/L) | INF-γ/ (pg/mL) |
|---|---|---|---|
| 菌阳肺结核组 | 62 | 4.97±0.50 | 15.19±2.66 |
| 菌阴肺结核组 | 88 | 4.26±0.47 | 10.29±3.57 |
| 非肺结核组 | 50 | 3.74±0.53 | 7.42±4.16 |
| F值 | 6.362 | 7.628 | |
| P值 | 0.000 | 0.000 |
| 组别 | 例数 | MMP-9/ (ng/L) | INF-γ/ (pg/mL) |
|---|---|---|---|
| 菌阳肺结核组 | 62 | 4.97±0.50 | 15.19±2.66 |
| 菌阴肺结核组 | 88 | 4.26±0.47 | 10.29±3.57 |
| 非肺结核组 | 50 | 3.74±0.53 | 7.42±4.16 |
| F值 | 6.362 | 7.628 | |
| P值 | 0.000 | 0.000 |
| 组别 | 例数 | INF-γ阳性/[例(%)] | Xpert MTB/RIF阳性/[例(%)] |
|---|---|---|---|
| 菌阳肺结核组 | 62 | 45(72.6) | 56(9.7) |
| 菌阴肺结核组 | 88 | 67(76.1) | 58(34.1) |
| χ2值 | 0.572 | 11.890 | |
| P值 | 0.194 | 0.000 |
| 组别 | 例数 | INF-γ阳性/[例(%)] | Xpert MTB/RIF阳性/[例(%)] |
|---|---|---|---|
| 菌阳肺结核组 | 62 | 45(72.6) | 56(9.7) |
| 菌阴肺结核组 | 88 | 67(76.1) | 58(34.1) |
| χ2值 | 0.572 | 11.890 | |
| P值 | 0.194 | 0.000 |
| 变量 | β值 | 标准误 | Wald值 | P值 | OR值(95%可信区间) |
|---|---|---|---|---|---|
| MMP-9 | 0.523 | 0.426 | 1.507 | 0.004 | 1.687(1.687~3.888) |
| INF-γ | 0.456 | 0.114 | 16.000 | 0.005 | 2.511(2.511~3.140) |
| Xpert MTB/RIF阳性 | 0.115 | 0.314 | 0.134 | 0.005 | 1.340(2.511~3.140) |
| 变量 | β值 | 标准误 | Wald值 | P值 | OR值(95%可信区间) |
|---|---|---|---|---|---|
| MMP-9 | 0.523 | 0.426 | 1.507 | 0.004 | 1.687(1.687~3.888) |
| INF-γ | 0.456 | 0.114 | 16.000 | 0.005 | 2.511(2.511~3.140) |
| Xpert MTB/RIF阳性 | 0.115 | 0.314 | 0.134 | 0.005 | 1.340(2.511~3.140) |
| 项目 | 真阳性/例 | 假阳性/例 | 真阴性/例 | 假阴性/例 | 敏感性/% | 特异性/% | 阳性预测值/% | 阴性预测值/% | 准确性/% |
|---|---|---|---|---|---|---|---|---|---|
| Xpert MTB/RIF检测 | 130 | 5 | 45 | 20 | 86.7 | 90.0 | 96.3 | 69.2 | 87.5 |
| INF-γ释放试验 | 120 | 19 | 31 | 30 | 80.0 | 62.0 | 86.3 | 50.2 | 75.5 |
| MMP-9 | 121 | 20 | 30 | 29 | 80.7 | 60.0 | 85.2 | 50.8 | 75.6 |
| 3项联合检测 | 136 | 11 | 39 | 14 | 90.7 | 78.0 | 92.5 | 73.6 | 87.5 |
| 项目 | 真阳性/例 | 假阳性/例 | 真阴性/例 | 假阴性/例 | 敏感性/% | 特异性/% | 阳性预测值/% | 阴性预测值/% | 准确性/% |
|---|---|---|---|---|---|---|---|---|---|
| Xpert MTB/RIF检测 | 130 | 5 | 45 | 20 | 86.7 | 90.0 | 96.3 | 69.2 | 87.5 |
| INF-γ释放试验 | 120 | 19 | 31 | 30 | 80.0 | 62.0 | 86.3 | 50.2 | 75.5 |
| MMP-9 | 121 | 20 | 30 | 29 | 80.7 | 60.0 | 85.2 | 50.8 | 75.6 |
| 3项联合检测 | 136 | 11 | 39 | 14 | 90.7 | 78.0 | 92.5 | 73.6 | 87.5 |
| [1] |
MURTHY S E, CHATTERJEE F, CROOK A, et al. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis[J]. BMC Med, 2018, 16(1):73.
DOI URL |
| [2] |
LAI S W, LIN C L, LIAO K F. Association between pulmonary tuberculosis and acid suppressive agents[J]. Postgrad Med J, 2020, 96(1133):165.
DOI URL |
| [3] |
RICHTERMAN A, STEER-MASSARO J, JAROLIMOVA J, et al. Cash interventions to improve clinical outcomes for pulmonary tuberculosis:systematic review and meta-analysis[J]. Bull World Health Organ, 2018, 96(7):471-483.
DOI URL |
| [4] | DABLOOL. Surveillance of one-year pulmonary tuberculosis cases at Al Taif province using different diagnostic tools[J]. Life Sciences, 2019, 16(3):27-32. |
| [5] |
YUSTE J R, SERRANO-ALONSO M, CARMONA-TORRE F, et al. Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis[J]. J Antimicrob Chemother, 2019, 74(9):2817-2819.
DOI URL |
| [6] |
SAAD J, BARON S, LAGIER J C, et al. Mycobacterium bovis pulmonary tuberculosis after ritual sheep sacrifice in Tunisia[J]. Emerg Infect Dis, 2020, 26(7):1605-1607.
DOI URL |
| [7] | 张永强, 刘兰瑞, 张雁, 等. XpertMTB/RIF技术对结核病以及耐药结核病的诊断应用价值[J]. 中国实验诊断学, 2018, 22(4):654-655. |
| [8] | 肺结核诊断WS 288—2017[J]. 中国感染控制杂志, 2018, 17(7):642-652. |
| [9] |
CONRADIE F, DIACON A H, NGUBANE N, et al. Treatment of highly drug-resistant pulmonary tuberculosis[J]. N Engl J Med, 2020, 382(10):893-902.
DOI URL |
| [10] |
SHUAIB Y A, KHALIL E A G, WIELER L H, et al. Mycobacterium tuberculosis complex lineage 3 as causative agent of pulmonary tuberculosis,Eastern Sudan[J]. Emerg Infect Dis, 2020, 26(3):427-436.
DOI URL |
| [11] |
CAMPRUBÍ D, GOMILA A, GRIJOTA-CAMINO M D, et al. Infectiousness of patients with smear-negative pulmonary tuberculosis,assessed by real-time polymerase chain reaction,Xpert® MTB/RIF[J]. J Infect, 2020, 80(3):298-300.
DOI URL |
| [12] | 吴小翠, 余方友. 结核病实验室诊断的进展及挑战[J]. 中华传染病杂志, 2021, 39(10):591-597. |
| [13] |
ZAR H J, NICOL M P. Strengthening diagnosis of pulmonary tuberculosis in children:the role of Xpert MTB/RIF ultra[J]. Pediatrics, 2019, 144(5):e20192944.
DOI URL |
| [14] | 郭志峰. 血清中期因子、血小板因子4和黏蛋白1含量检测对乳腺癌患者病情评估的价值[J]. 中国医药导报, 2017, 14(11):99-102. |
| [15] | 李榜龙, 鲁学明, 周外民. 贞芪扶正颗粒对肺结核化疗患者免疫功能及炎症因子的影响[J]. 中国煤炭工业医学杂志, 2018, 21(5):463-467. |
| [16] | 余艳艳, 谭云洪, 朱权, 等. INF-γ和IL-2联合检测在结核病辅助诊断中的价值[J]. 检验医学与临床, 2019, 16(11):1477-1479. |
| [17] | 林永通, 麦世康. GeneXpert Mtb/RIF检测技术在结核病诊断中的应用评价[J]. 中国热带医学, 2018, 18(1):93-95. |
| [18] | 熊梦园, 方芳, 李一荣. Xpert MTB/RIF检测技术对肺结核的诊断价值[J]. 海南医学, 2020, 31(5):554-558. |
| [19] | 廖彥, 林翀, 林明冠, 等. 血清基质金属蛋白酶-9在肺结核鉴别诊断中的价值分析[J]. 中国免疫学杂志, 2018, 34(10):1542-1546. |
| [20] | 王浩, 徐叶红, 郝建, 等. TB-IGRA对肺结核的诊断价值及假阴性影响因素探讨[J]. 临床肺科杂志, 2018, 23(7):1190-1193. |
| [1] | FU Ai. Relationship between serum miR-125b and miR-423 expressions in patients with pulmonary tuberculosis and the disease activity and prognosis [J]. Laboratory Medicine, 2025, 40(9): 862-866. |
| [2] | WU Qi, ZOU Yan, ZHANG Yanxia, CHEN Ligang. Diagnostic value of Xpert MTB/RIF combined with BD-960 rapid culture and Roche culture in BALF for bacteriological negative pulmonary tuberculosis [J]. Laboratory Medicine, 2025, 40(8): 793-797. |
| [3] | GUI Jing, WANG Feng, CAI Yumao, HONG Chuangyue, YANG Hui. Correlation between oxidized high-density lipoprotein and comorbidity of T2DM and PTB [J]. Laboratory Medicine, 2025, 40(4): 350-357. |
| [4] | ZHANG Guoying, LU Zhongkui, WANG Yuling, XIA Xia, MENG Ke, HE Fang, HUANG Zihui, YANG Zengmin, LIU Xin. Application of gamma-interferon inducible protein-10 mRNA determination technology in diagnosis of extrapulmonary tuberculosis [J]. Laboratory Medicine, 2025, 40(4): 372-376. |
| [5] | CHEN Qiuying, ZHANG Lei, ZHOU Shupei, YAO Miaomiao, WANG Lirong, YIN Haibo, LI Xin. Correlation between serum NRG-1 and MMP-9 levels and cognitive function of patients with stable schizophrenia [J]. Laboratory Medicine, 2025, 40(11): 1091-1096. |
| [6] | HUANG Ying, ZHOU Ying, SONG Yunxiao, MAO Junjie, GUAN Chao, ZHAO Jinyan, NI Peiqing. Pulmonary tuberculosis diagnosis model for blood routine test based on machine learning algorithms [J]. Laboratory Medicine, 2024, 39(7): 668-672. |
| [7] | LIU Jian, XU Hui, YANG Yongqiong, DENG Zhengbo. Roles of serum miR-129-3p and miR-144-3p in drug-resistant pulmonary tuberculosis patients [J]. Laboratory Medicine, 2024, 39(11): 1113-1117. |
| [8] | SUN Xinlin, YE Xingming, LI Qian, ZHAO Lijun. Bronchoscopy combined with sputum Mycobacterium tuberculosis ribonucleic acid and serum Mycobacterium tuberculosis specific antibody determinations for diagnosis of negative pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(9): 870-873. |
| [9] | MIAO Xingguo, YE Hui, SU Feifei. Relationship between GeneXpert MTB/RIF assay determination load and Mycobacterium tuberculosis culture and phenotype of rifampicin resistance [J]. Laboratory Medicine, 2023, 38(9): 874-877. |
| [10] | GAI Linlin, LI Haibo, CHU Jinjin, SUN Jiamei, YAN Xinyi, DU Jinke, DAI Wenqing, XU Donghua. Role of chemiluminescence interferon gamma release assay in auxiliary diagnosis of pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(3): 257-260. |
| [11] | ZHANG Guoying, HE Fang, XIA Xia, GUO Yidi, XU Weiping, HUANG Zihui. Diagnosis value of Xpert MTB/RIF assay for different types of lymph node tuberculosis [J]. Laboratory Medicine, 2021, 36(9): 935-938. |
| [12] | LI Dian, ZHENG Zheng, JIANG Yezhou. Roles of serum GM-CSF,sTREM-1 combined with T-SPOT.TB in the differential diagnosis of pulmonary tuberculosis [J]. Laboratory Medicine, 2021, 36(8): 833-836. |
| [13] | LIN Xiaoling, LIANG Lifeng, WU Yingtao, ZHAO Jieming, CAI Qiuyue. An drug resistance analysis on the mycobacterium tuberculosis complex of pulmonary tuberulosis in Yunfu city [J]. Laboratory Medicine, 2021, 36(2): 194-197. |
| [14] | FENG Zhishan, LI Guixia, LIU Jianhua, GUO Weiwei, ZHANG Wenchao, ZHANG Lixia, HUANG Hui, WANG Le. Clinical evaluation of 3 methods for the determination of Mycoplasma pneumoniae infection in children [J]. Laboratory Medicine, 2019, 34(9): 808-811. |
| [15] | Xi'an YANG Jian, ZHANG Tianhua, XIAN Xiaoping, LI Yan, CHEN Meiling, WANG Rui. Drug resistance of 218 isolates of Mycobacterium tuberculosis in [J]. Laboratory Medicine, 2019, 34(5): 421-427. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||